We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
0
0 active
Approvals
41
Total approvals
Agencies
3
Regulatory bodies
Founded
N/A
No trial phase data available
No trial data available
NMPA
National Medical Products Administration
FDA
Food and Drug Administration
27
CANADA
Health Canada
11
- Dr. Kandiraju Venkata Sitaram Rao has resigned from his position as Joint Managing Director and CEO of Granules India Limited, effective July 31, 2025. - The pharmaceutical executive brings over 29 years of experience in manufacturing, R&D, and business operations to his departure from the Indian generic drug manufacturer. - Granules India has acknowledged the resignation and is implementing measures to ensure a seamless leadership transition over the coming weeks. - Dr. Rao previously held senior leadership positions at PI Industries, Dr. Reddy's Laboratories, Jubilant Life Sciences, and Gujarat Heavy Chemicals Ltd.
